Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation?

P. Rožman*, M. Karas, A. Košir, B. Labar, A. Madrigal, D. Middleton, C. Navarrete, M. Oudshoorn, H. Schennach, A. Vitek, M. Bohinjec, T. Dovč, T. Ficko, B. Vidan-Jeras, M. Jeras, J. Pretnar, J. Jazbec, A. M. van Walraven, P. Jindrà, I. KarlachovaH. Schmarda, D. Nachbaur, A. Kaštelan, M. Pisk, E. Čeǔk, B. Golubić, Z. Ivanković, D. Middleton, M. F. McMullin, D. Sage, A. Pay

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

11 Citations (Scopus)


The role of human platelet alloantigens (HPA) in clinical bone marrow allotransplantation was investigated. The leading hypothesis was that HPA alloepitopes act as minor histocompatibility antigens and aggravate graft-versus-host disease (GVHD). To exclude the effect of MHC disparity, only HLA identical donor-recipient pairs were entered into the study. The influence of HPA compatibility on overall survival, occurrence of relapses and haematopoietic recovery was also investigated. A total of 223 patients who received a graft from an HLA-identical sibling, genotyped for HPA -1, -2, -3, -4 and -5, were observed over a post-transplant period of 24 months following the protocol recommended by EBMT. The data from patients having received grafts from HPA compatible donors were compared to data from patients having received grafts that were mismatched in HPA allotypes in the GVH direction. Analysis of the incidence of acute and chronic (GVHD), overall survival, relapse incidence, haematopoietic recovery and some other clinical parameters did not reveal any significant difference between the HPA-matched and -mismatched groups of patients, regardless of their age. Our results give no evidence that HPA-1, -2, -3 and -5 alloantigens should be considered minor transplantation antigens in clinical bone marrow transplantation.

Original languageEnglish
Pages (from-to)497-506
Number of pages10
JournalBone Marrow Transplantation
Issue number6
Publication statusPublished - 01 Mar 2003


  • Glycoproeteins
  • Graft-versus-host disease
  • Haematopoietic recovery
  • Histocompatibility
  • Polymorphism

ASJC Scopus subject areas

  • Hematology
  • Transplantation


Dive into the research topics of 'Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation?'. Together they form a unique fingerprint.

Cite this